AMRUTANJAN vs GRANULES: Stock Comparison

AMRUTAJAN HEALTH vs GRANULES INDIAUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

GRANULES INDIA is the larger company by market capitalisation. AMRUTAJAN HEALTH shows a lower P/E, a higher ROE and a higher dividend yield, while GRANULES INDIA shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

AMRUTANJAN leads 7; GRANULES leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

AMRUTANJANGRANULES

Valuation lens

What price are you paying?

Market CapContext only
₹1,451 Cr
₹21,073 Cr
P/E RatioAMRUTANJAN has the lower reading
0x
31.03x
P/B RatioAMRUTANJAN has the lower reading
0x
4.08x
EPSGRANULES has the higher reading
₹1.51
₹2.9
Book ValueContext only
₹128.06
₹205.21
Dividend YieldAMRUTANJAN has the higher reading
0.92%
0.21%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
GRANULES is the larger company
₹21,073 Cr vs ₹1,451 Cr
P/E Ratio
AMRUTANJAN has a lower P/E
0x vs 31.03x
P/B Ratio
AMRUTANJAN has a lower P/B
0x vs 4.08x
EPS
GRANULES has higher earnings per share
₹2.9 vs ₹1.51
Dividend Yield
AMRUTANJAN has a higher dividend yield
0.92% vs 0.21%
Revenue Growth (TTM YoY)
GRANULES has faster revenue growth
22.8% vs 10.5%
EPS Growth (TTM YoY)
GRANULES has faster EPS growth
31.3% vs 6.7%
Qtr Sales Growth
GRANULES has stronger quarterly sales growth
-45.7% vs -79.51%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAMRUTANJANGRANULES
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricAMRUTANJANGRANULES
Live Price₹505.45₹848.3
Day Change-0.37%-0.65%
Volume41,06911.73 L
52-Week High₹790.95₹910
52-Week Low₹482.8₹507.3
Distance from 52W High-36.1%-6.78%

Valuation

MetricAMRUTANJANGRANULES
Market Cap₹1,451 Cr₹21,073 Cr
P/E Ratio0x31.03x
P/B Ratio0x4.08x
EPS₹1.51₹2.9
Book Value₹128.06₹205.21
Dividend Yield0.92%0.21%

Growth

MetricAMRUTANJANGRANULES
Revenue Growth (TTM YoY)10.5%22.8%
EPS Growth (TTM YoY)6.7%31.3%
Qtr Sales Growth-79.51%-45.7%
Qtr Profit Growth-92.46%-60.13%

Profitability & Leverage

MetricAMRUTANJANGRANULES
ROE15.64%11.7%
ROCE16.18%12.47%
Net Margin11.52%11.15%
Operating Margin15.54%16.76%
Debt to Equity0x0.26x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricAMRUTANJANGRANULES
Promoter Holding46.52%37.67%
FII Holding2.44% 0.27 pp17.5% 2.19 pp
DII Holding12.28% 0.38 pp16.11% 0.9 pp
Public Holding38.72% 0.11 pp28.38% 1.28 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AMRUTAJAN HEALTH and GRANULES INDIA.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.